CL2014000799A1 - Un metodo para el tratamiento de un paciente que ha sufrido un accidente cerebrovascular que comprende administrar aminopiridina o una de sus sales - Google Patents
Un metodo para el tratamiento de un paciente que ha sufrido un accidente cerebrovascular que comprende administrar aminopiridina o una de sus salesInfo
- Publication number
- CL2014000799A1 CL2014000799A1 CL2014000799A CL2014000799A CL2014000799A1 CL 2014000799 A1 CL2014000799 A1 CL 2014000799A1 CL 2014000799 A CL2014000799 A CL 2014000799A CL 2014000799 A CL2014000799 A CL 2014000799A CL 2014000799 A1 CL2014000799 A1 CL 2014000799A1
- Authority
- CL
- Chile
- Prior art keywords
- suffered
- stroke
- salts
- patient
- treatment
- Prior art date
Links
- 150000003927 aminopyridines Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161543150P | 2011-10-04 | 2011-10-04 | |
| US201261591833P | 2012-01-27 | 2012-01-27 | |
| US201261648695P | 2012-05-18 | 2012-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014000799A1 true CL2014000799A1 (es) | 2014-11-03 |
Family
ID=47143280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014000799A CL2014000799A1 (es) | 2011-10-04 | 2014-04-02 | Un metodo para el tratamiento de un paciente que ha sufrido un accidente cerebrovascular que comprende administrar aminopiridina o una de sus sales |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20130085167A1 (enExample) |
| EP (1) | EP2766017B1 (enExample) |
| JP (1) | JP6134722B2 (enExample) |
| KR (1) | KR20140084120A (enExample) |
| CN (2) | CN108451953A (enExample) |
| AR (1) | AR088764A1 (enExample) |
| AU (2) | AU2012318719B2 (enExample) |
| BR (1) | BR112014008082A8 (enExample) |
| CA (1) | CA2850635A1 (enExample) |
| CL (1) | CL2014000799A1 (enExample) |
| CO (1) | CO7061067A2 (enExample) |
| CR (1) | CR20140153A (enExample) |
| EA (1) | EA029558B1 (enExample) |
| HK (1) | HK1201204A1 (enExample) |
| IL (1) | IL231809B (enExample) |
| MX (1) | MX354667B (enExample) |
| PH (1) | PH12014500739B1 (enExample) |
| SG (2) | SG10201600410SA (enExample) |
| TW (1) | TWI592156B (enExample) |
| UA (1) | UA114486C2 (enExample) |
| WO (1) | WO2013052575A1 (enExample) |
| ZA (1) | ZA201402432B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014172266A1 (en) * | 2013-04-15 | 2014-10-23 | Acorda Therapeutics, Inc. | Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines |
| US10172842B2 (en) | 2015-09-11 | 2019-01-08 | PharmaDax Inc. | Sustained release oral dosage form containing dalfampridine |
| DE102017115701B4 (de) * | 2017-07-12 | 2022-03-03 | Lts Lohmann Therapie-Systeme Ag | Fampridin-TTS |
| CN109172573B (zh) * | 2018-09-12 | 2021-01-26 | 黑龙江中桂制药有限公司 | 一种口服抗血栓药物及其用途 |
| CN115018836A (zh) * | 2022-08-08 | 2022-09-06 | 四川大学 | 一种癫痫病灶自动分割与预测方法、系统及设备 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0696575B2 (ja) * | 1987-09-17 | 1994-11-30 | 三菱化成株式会社 | ４−アミノピリジン誘導体及びその酸付加塩 |
| WO1989009600A1 (en) | 1988-04-08 | 1989-10-19 | Massachusetts Institute Of Technology | Method and composition for treating neurological disorders |
| IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| CA2085785C (en) * | 1992-12-18 | 2005-03-15 | Robert R. Hansebout | The use of 4-aminopyridine in the treatment of a neurological condition |
| US5952357A (en) | 1993-12-23 | 1999-09-14 | Cornell Research Foundation, Inc. | Treating diseases of the anterior horn cells |
| DE60034110T2 (de) * | 1999-02-09 | 2007-12-06 | The Uab Research Foundation, Birmingham | Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien |
| FR2791571B1 (fr) * | 1999-04-02 | 2002-10-04 | Sod Conseils Rech Applic | Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s) |
| CA2403555A1 (en) * | 2000-03-28 | 2001-10-04 | Queen's University At Kingston | Methods for effecting neuroprotection |
| GB0119435D0 (en) * | 2001-02-15 | 2001-10-03 | Aventis Pharm Prod Inc | Method of treating of demyelinating diseases or conditions |
| US8007826B2 (en) | 2003-12-11 | 2011-08-30 | Acorda Therapeutics, Inc. | Sustained release aminopyridine composition |
| US8354437B2 (en) | 2004-04-09 | 2013-01-15 | Acorda Therapeutics, Inc. | Method of using sustained release aminopyridine compositions |
| EP2667869A1 (en) * | 2011-01-28 | 2013-12-04 | Acorda Therapeutics, Inc. | Use of potassium channel blockers to treat cerebral palsy |
-
2012
- 2012-10-03 TW TW101136564A patent/TWI592156B/zh not_active IP Right Cessation
- 2012-10-04 WO PCT/US2012/058607 patent/WO2013052575A1/en not_active Ceased
- 2012-10-04 CN CN201810257441.8A patent/CN108451953A/zh active Pending
- 2012-10-04 UA UAA201403422A patent/UA114486C2/uk unknown
- 2012-10-04 SG SG10201600410SA patent/SG10201600410SA/en unknown
- 2012-10-04 KR KR1020147012028A patent/KR20140084120A/ko not_active Ceased
- 2012-10-04 MX MX2014003997A patent/MX354667B/es active IP Right Grant
- 2012-10-04 JP JP2014534667A patent/JP6134722B2/ja not_active Expired - Fee Related
- 2012-10-04 EP EP12781519.9A patent/EP2766017B1/en active Active
- 2012-10-04 SG SG11201401248YA patent/SG11201401248YA/en unknown
- 2012-10-04 CN CN201280059695.XA patent/CN104220072B/zh not_active Expired - Fee Related
- 2012-10-04 AR ARP120103710A patent/AR088764A1/es unknown
- 2012-10-04 BR BR112014008082A patent/BR112014008082A8/pt not_active Application Discontinuation
- 2012-10-04 PH PH1/2014/500739A patent/PH12014500739B1/en unknown
- 2012-10-04 EA EA201490562A patent/EA029558B1/ru not_active IP Right Cessation
- 2012-10-04 AU AU2012318719A patent/AU2012318719B2/en not_active Ceased
- 2012-10-04 HK HK15101829.8A patent/HK1201204A1/xx unknown
- 2012-10-04 CA CA2850635A patent/CA2850635A1/en not_active Abandoned
- 2012-10-04 US US13/644,990 patent/US20130085167A1/en not_active Abandoned
-
2014
- 2014-03-30 IL IL231809A patent/IL231809B/en active IP Right Grant
- 2014-04-02 CL CL2014000799A patent/CL2014000799A1/es unknown
- 2014-04-02 ZA ZA2014/02432A patent/ZA201402432B/en unknown
- 2014-04-04 CO CO14072652A patent/CO7061067A2/es not_active Application Discontinuation
- 2014-04-04 CR CR20140153A patent/CR20140153A/es unknown
-
2015
- 2015-09-08 US US14/848,324 patent/US20160067232A1/en not_active Abandoned
-
2018
- 2018-01-05 AU AU2018200114A patent/AU2018200114A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013033803A2 (pt) | formulação integrada com microagulha, e, método para administrar uma substância | |
| DK2709667T3 (da) | Bio-orthogonal lægemiddelaktivering | |
| ECSP14013329A (es) | Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas | |
| CL2013002612A1 (es) | Compuestos derivados de c4-monometil triterpenoides; composicion farmaceutica que los comprende; y metodo para tratar o prevenir una enfermedad o un trastorno. | |
| PL2672911T3 (pl) | Urządzenie do wykonywania zabiegów laserowych na skórze | |
| DK3750545T3 (da) | Phospholipidetheranaloger som cancermålrettede lægemiddelbærere | |
| UY33863A (es) | Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer | |
| IL243481A0 (en) | Drug for treatment of nonalcoholic fatty liver disease | |
| BR112013028273A2 (pt) | método para estimular um procedimento médico e artigo | |
| CO6820281A1 (es) | Cepillo de dientes que proporciona retroalimentación prácticamente instantanea | |
| CO7061081A2 (es) | Derivados macrocíclicos para el tratamiento de enfermedades | |
| BR112017009342A2 (pt) | formulações e tratamentos para cuidado com a pele | |
| IL235512B (en) | Phenylbenzamide derivatives for use in treating diseases mediated by aquaporin | |
| UY34165A (es) | ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?. | |
| BR112014026570A2 (pt) | microagulha, arranjo e dispositivo de microagulha, e, método para administração de uma droga | |
| CL2015000744A1 (es) | Combinación de regorafenib y ácido acetilsalicílico para el tratamiento del cáncer. | |
| BR112013014546A2 (pt) | dispositivo e método para administração de um dispositivo vascular | |
| BR112013029507A2 (pt) | método para tratar uma doença ou um distúrbio | |
| DK3229873T3 (da) | Drivmekanisme til anvendelse i en lægemiddelleveringsanordning | |
| EP2773419A4 (en) | IMPLANTABLE MEDICAL PASSIVE ELECTRODE | |
| CL2014000799A1 (es) | Un metodo para el tratamiento de un paciente que ha sufrido un accidente cerebrovascular que comprende administrar aminopiridina o una de sus sales | |
| CO6821965A2 (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
| BR112014000217A2 (pt) | formulação e método para a criação de uma formulação que estabiliza a proteína terapêutica | |
| MA43100A (fr) | Nanoparticules à utiliser en tant que vaccin thérapeutique | |
| CO7121334A2 (es) | Formulaciones vesiculares |